应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CASI 凯信远达
交易中 05-20 10:52:41 EDT
3.07
-0.23
-6.88%
最高
3.49
最低
3.07
成交量
1.06万
今开
3.38
昨收
3.30
日振幅
12.63%
总市值
3,992万
流通市值
1,672万
总股本
1,299万
成交额
3.50万
换手率
0.19%
流通股本
543.94万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
凯信远达下跌2.42%,报3.22美元/股
金融界 · 57分钟前
凯信远达下跌2.42%,报3.22美元/股
凯信远达下跌2.75%,报3.18美元/股
金融界 · 05-16
凯信远达下跌2.75%,报3.18美元/股
HC Wainwright & Co.:维持CASI Pharmaceuticals(CASI.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至6.00美元。
智通财经 · 05-15
HC Wainwright & Co.:维持CASI Pharmaceuticals(CASI.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至6.00美元。
凯信远达上涨3.31%,报2.65美元/股
金融界 · 05-15
凯信远达上涨3.31%,报2.65美元/股
凯信远达盘中异动 早盘快速下跌5.26%
自选股智能写手 · 05-14
凯信远达盘中异动 早盘快速下跌5.26%
凯信远达下跌9.43%,报2.4美元/股
金融界 · 05-14
凯信远达下跌9.43%,报2.4美元/股
凯信远达下跌2.83%,报2.549美元/股
金融界 · 05-10
凯信远达下跌2.83%,报2.549美元/股
凯信远达盘中异动 股价大涨5.14%
自选股智能写手 · 05-10
凯信远达盘中异动 股价大涨5.14%
凯信远达下跌6.06%,报2.48美元/股
金融界 · 05-09
凯信远达下跌6.06%,报2.48美元/股
凯信远达盘中异动 快速跳水6.06%
自选股智能写手 · 05-09
凯信远达盘中异动 快速跳水6.06%
凯信远达下跌5.82%,报2.59美元/股
金融界 · 05-08
凯信远达下跌5.82%,报2.59美元/股
凯信远达盘中异动 下午盘快速下挫5.82%
自选股智能写手 · 05-08
凯信远达盘中异动 下午盘快速下挫5.82%
凯信远达盘中异动 临近收盘急速拉升6.34%
自选股智能写手 · 05-04
凯信远达盘中异动 临近收盘急速拉升6.34%
凯信远达上涨3.39%,报2.771美元/股
金融界 · 05-04
凯信远达上涨3.39%,报2.771美元/股
凯信远达上涨7.49%,报2.569美元/股
金融界 · 05-02
凯信远达上涨7.49%,报2.569美元/股
凯信远达盘中异动 大幅上涨7.49%报2.57美元
自选股智能写手 · 05-02
凯信远达盘中异动 大幅上涨7.49%报2.57美元
凯信远达下跌2.99%,报2.27美元/股
金融界 · 05-01
凯信远达下跌2.99%,报2.27美元/股
凯信远达盘中异动 下午盘快速下挫5.37%
自选股智能写手 · 04-30
凯信远达盘中异动 下午盘快速下挫5.37%
凯信远达下跌5.37%,报2.29美元/股
金融界 · 04-30
凯信远达下跌5.37%,报2.29美元/股
加载更多
公司概况
公司名称:
凯信远达
所属市场:
NASDAQ
上市日期:
--
主营业务:
凯信远达医药公司于1991年注册成立,是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司,专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司,致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法,这将扩大血液学/肿瘤学特许经营权。
发行价格:
--
{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":3.0731,"timestamp":1716216003525,"preClose":3.3,"halted":0,"volume":10585,"delay":0,"floatShares":5439391,"shares":12989423,"eps":-2.279577,"marketStatus":"交易中","marketStatusCode":2,"change":-0.2269,"latestTime":"05-20 10:52:41 EDT","open":3.38,"high":3.49,"low":3.0731,"amount":34981.885941,"amplitude":0.126333,"askPrice":3.24,"askSize":100,"bidPrice":3.08,"bidSize":158,"shortable":3,"etf":0,"ttmEps":-2.279577,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716235200000},"adr":0,"listingDate":834552000000,"adjPreClose":3.3,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.3,"preClose":3.3,"latestTime":"07:33 EDT","volume":255,"amount":840.4999919999999,"timestamp":1716204830105},"postHourTrading":{"tag":"盘后","latestPrice":3.49,"preClose":3.3,"latestTime":"17:21 EDT","volume":1030,"amount":3425.91,"timestamp":1715980910549},"volumeRatio":1.54783},"requestUrl":"/m/hq/s/CASI","defaultTab":"news","newsList":[{"id":"2436106603","title":"凯信远达下跌2.42%,报3.22美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2436106603","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2436106603?lang=zh_cn&edition=full","pubTime":"2024-05-20 21:56","pubTimestamp":1716213387,"startTime":"0","endTime":"0","summary":"5月20日,凯信远达(CASI)盘中下跌2.42%,截至21:56,报3.22美元/股,成交2.21万美元。财务数据显示,截至2024年03月31日,凯信远达收入总额340.9万美元,同比减少59.16%;归母净利润-952.8万美元,同比减少58.56%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/20215640710816.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435160464","title":"凯信远达下跌2.75%,报3.18美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435160464","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435160464?lang=zh_cn&edition=full","pubTime":"2024-05-16 23:42","pubTimestamp":1715874164,"startTime":"0","endTime":"0","summary":"5月16日,凯信远达(CASI)盘中下跌2.75%,截至23:42,报3.18美元/股,成交3.31万美元。财务数据显示,截至2024年03月31日,凯信远达收入总额340.9万美元,同比减少59.16%;归母净利润-952.8万美元,同比减少58.56%。大事提醒:5月15日,凯信远达2024财年一季报归属股东应占溢利-952.8万美元,同比下降58.56%,基本每股收益-0.71美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/16234240676213.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435490652","title":"HC Wainwright & Co.:维持CASI Pharmaceuticals(CASI.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435490652","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435490652?lang=zh_cn&edition=full","pubTime":"2024-05-15 23:55","pubTimestamp":1715788506,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持CASI Pharmaceuticals(CASI.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152355108b0bbd03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152355108b0bbd03&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435428225","title":"凯信远达上涨3.31%,报2.65美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435428225","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435428225?lang=zh_cn&edition=full","pubTime":"2024-05-15 02:38","pubTimestamp":1715711886,"startTime":"0","endTime":"0","summary":"5月15日,凯信远达(CASI)盘中上涨3.31%,截至02:38,报2.65美元/股,成交4.41万美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/15023840646392.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435096517","title":"凯信远达盘中异动 早盘快速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435096517","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435096517?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:52","pubTimestamp":1715698344,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日22时52分,凯信远达股票出现异动,股价大幅下跌5.26%。截至发稿,该股报2.43美元/股,成交量3555股,换手率0.03%,振幅1.04%。凯信远达股票所在的生物技术行业中,整体跌幅为0.33%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514225224861ed204&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514225224861ed204&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435824305","title":"凯信远达下跌9.43%,报2.4美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435824305","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435824305?lang=zh_cn&edition=full","pubTime":"2024-05-14 01:29","pubTimestamp":1715621349,"startTime":"0","endTime":"0","summary":"5月14日,凯信远达(CASI)盘中下跌9.43%,截至01:29,报2.4美元/股,成交1.49万美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/14012940629641.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434652568","title":"凯信远达下跌2.83%,报2.549美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434652568","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434652568?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:48","pubTimestamp":1715356104,"startTime":"0","endTime":"0","summary":"5月10日,凯信远达(CASI)盘中下跌2.83%,截至23:48,报2.549美元/股,成交9716.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/10234840606520.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434851100","title":"凯信远达盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434851100","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434851100?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:32","pubTimestamp":1715347965,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时32分,凯信远达股票出现异动,股价急速上涨5.14%。截至发稿,该股报2.76美元/股,成交量262股,换手率0.00%,振幅0.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中,整体涨幅为0.08%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213245861ec6c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213245861ec6c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434016865","title":"凯信远达下跌6.06%,报2.48美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434016865","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434016865?lang=zh_cn&edition=full","pubTime":"2024-05-09 22:23","pubTimestamp":1715264606,"startTime":"0","endTime":"0","summary":"5月9日,凯信远达(CASI)盘中下跌6.06%,截至22:23,报2.48美元/股,成交4112.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/09222340588009.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434301938","title":"凯信远达盘中异动 快速跳水6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434301938","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434301938?lang=zh_cn&edition=full","pubTime":"2024-05-09 22:23","pubTimestamp":1715264598,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日22时23分,凯信远达股票出现异动,股价快速下跌6.06%。截至发稿,该股报2.48美元/股,成交量1454股,换手率0.01%,振幅1.14%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中,整体涨幅为0.34%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509222318861ec1fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509222318861ec1fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433733553","title":"凯信远达下跌5.82%,报2.59美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733553","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433733553?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:27","pubTimestamp":1715102867,"startTime":"0","endTime":"0","summary":"5月8日,凯信远达(CASI)盘中下跌5.82%,截至01:27,报2.59美元/股,成交4188.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/08012740555632.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433173339","title":"凯信远达盘中异动 下午盘快速下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433173339","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433173339?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:27","pubTimestamp":1715102849,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时27分,凯信远达股票出现异动,股价大幅跳水5.82%。截至发稿,该股报2.59美元/股,成交量1450股,换手率0.01%,振幅5.27%。凯信远达股票所在的生物技术行业中,整体涨幅为1.10%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801272979264f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801272979264f92&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432366071","title":"凯信远达盘中异动 临近收盘急速拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432366071","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432366071?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:58","pubTimestamp":1714766302,"startTime":"0","endTime":"0","summary":"北京时间2024年05月04日03时58分,凯信远达股票出现异动,股价快速拉升6.34%。截至发稿,该股报2.85美元/股,成交量9413股,换手率0.07%,振幅7.09%。凯信远达股票所在的生物技术行业中,整体涨幅为0.77%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040358227a57feb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040358227a57feb8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432918951","title":"凯信远达上涨3.39%,报2.771美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432918951","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432918951?lang=zh_cn&edition=full","pubTime":"2024-05-04 01:09","pubTimestamp":1714756168,"startTime":"0","endTime":"0","summary":"5月4日,凯信远达(CASI)盘中上涨3.39%,截至01:09,报2.771美元/股,成交1.2万美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/04010940516612.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432983231","title":"凯信远达上涨7.49%,报2.569美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432983231","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432983231?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:37","pubTimestamp":1714660648,"startTime":"0","endTime":"0","summary":"5月2日,凯信远达(CASI)盘中上涨7.49%,截至22:37,报2.569美元/股,成交3386.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/02223740511697.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432515988","title":"凯信远达盘中异动 大幅上涨7.49%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432515988","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432515988?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:37","pubTimestamp":1714660644,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时37分,凯信远达股票出现波动,股价快速上涨7.49%。截至发稿,该股报2.57美元/股,成交量1312股,换手率0.01%,振幅1.26%。凯信远达股票所在的生物技术行业中,整体涨幅为0.30%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502223725861eab50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502223725861eab50&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432307844","title":"凯信远达下跌2.99%,报2.27美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432307844","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432307844?lang=zh_cn&edition=full","pubTime":"2024-05-01 02:17","pubTimestamp":1714501072,"startTime":"0","endTime":"0","summary":"5月1日,凯信远达(CASI)盘中下跌2.99%,截至02:17,报2.27美元/股,成交6566.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/01021740501357.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431159848","title":"凯信远达盘中异动 下午盘快速下挫5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431159848","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431159848?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:02","pubTimestamp":1714410176,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时02分,凯信远达股票出现异动,股价大幅下跌5.37%。截至发稿,该股报2.29美元/股,成交量1852股,换手率0.01%,振幅2.02%。凯信远达股票所在的生物技术行业中,整体涨幅为0.84%。凯信远达公司简介:CASI Pharmaceuticals Inc是一家生物制药公司,致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001025787e84cb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001025787e84cb4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431010816","title":"凯信远达下跌5.37%,报2.29美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431010816","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431010816?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:02","pubTimestamp":1714410175,"startTime":"0","endTime":"0","summary":"4月30日,凯信远达(CASI)盘中下跌5.37%,截至01:02,报2.29美元/股,成交4611.0美元。财务数据显示,截至2023年12月31日,凯信远达收入总额3387.9万美元,同比减少21.41%;归母净利润-2693.8万美元,同比增长34.32%。大事提醒:5月15日,凯信远达将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/30010240479631.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.2453},{"period":"1month","weight":0.4732},{"period":"3month","weight":-0.431},{"period":"6month","weight":-0.2826},{"period":"1year","weight":0.5},{"period":"ytd","weight":-0.5391}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立,是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司,专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司,致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法,这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.175785},{"month":2,"riseRate":0.357143,"avgChangeRate":-0.007195},{"month":3,"riseRate":0.321429,"avgChangeRate":0.000453},{"month":4,"riseRate":0.392857,"avgChangeRate":0.035566},{"month":5,"riseRate":0.25,"avgChangeRate":0.043207},{"month":6,"riseRate":0.423077,"avgChangeRate":-0.036638},{"month":7,"riseRate":0.214286,"avgChangeRate":-0.074566},{"month":8,"riseRate":0.321429,"avgChangeRate":-0.028621},{"month":9,"riseRate":0.5,"avgChangeRate":0.010846},{"month":10,"riseRate":0.642857,"avgChangeRate":0.100523},{"month":11,"riseRate":0.392857,"avgChangeRate":0.045763},{"month":12,"riseRate":0.25,"avgChangeRate":-0.092857}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}